Effect of Melatonin and Modafinil on Acute Hepatic Failure in Mice

Zhouhua Hou

2005-01-01

Abstract:[Objective] To investigate the effect of melatonin and modafinil on acute hepatic failure in mice. [Methods] Acute liver failure was induced in male Kunming strain mice by enterocoelia injection of D-Gal N and LPS .The melatonin and modafinil were given orally to the mice in treatment groups 2 hr before administration of D-Gal N and LPS, and the same dose of distilled water were given orally to the mice in control group. The 24-hr survival rate, serum alanine aminotransferase(ALT), aspartate aminotransferase(AST) levels were compared. Serum levels of TNF-α and IL-1 and the levels of SOD, MDA, GR, GSH, NO and NOS in the liver were determined. [Results] D-Gal N and LPS could cause a acute hepatic failure. Treatment with melatonin increased survival rate and improved liver histological feather in acute hepatic failure mice induced by D-Gal N and LPS. melatonin inhibited serum levels of ALT, AST, TNF-α and IL-1, and reduced levels of MDA, NO and NOS and increased levels of GR and SOD in the liver. Modafinil worsened liver damage, elevated serum levels of ALT, AST, TNF-α and IL-1, increased level of MDA and inhabited SOD, GR activity in the liver. [Conclusion] Treatment with melatonin could improved the D-Gal N/LPS-induced acute hepatic failure but modafinil deteriorated it. It was suggested that melatonin could improved progress of acute hepatic failure by affecting production of inflammatory cytokines (such as TNF-α and IL-1) and alterring oxidation in acute hepatic failure mice induced by D-Gal N and LPS.